In addition, resveratrol (a SIRT1 agonist) treatment suppressed the over-expression of pro-inflammatory molecules and decreased acute lung injury in a sepsis mouse model induced by LPS via activation of SIRT1 and elimination of the oxidative stress (Chiavaroli et al., 2010; Li et al., 2013). The gene discussed is SIRT1; the disease is Sepsis.